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Abstract
Background: Recent epidemiological analyses have implicated acute Campylobacter enteritis as a factor that may
incite or exacerbate inflammatory bowel disease (IBD) in susceptible individuals. We have demonstrated previously
that C. jejuni disrupts the intestinal barrier function by rapidly inducing epithelial translocation of non-invasive
commensal bacteria via a transcellular lipid raft-mediated mechanism (’transcytosis’). To further characterize this
mechanism, the aim of this current study was to elucidate whether C. jejuni utilizes M cells to facilitate transcytosis
of commensal intestinal bacteria.
Results: C. jejuni induced translocation of non-invasive E. coli across confluent Caco-2 epithelial monolayers in the
absence of disrupted transepithelial electrical resistance or increased permeability to a 3 kDa dextran probe. C.
jejuni-infected monolayers displayed increased numbers of cells expressing the M cell-specific marker, galectin-9,
reduced numbers of enterocytes that stained with the absorptive enterocyte marker, Ulex europaeus agglutinin-1,
and reduced activities of enzymes typically associated with absorptive enterocytes (namely alkaline phosphatase,
lactase, and sucrase). Furthermore, in Campylobacter-infected monolayers, E. coli were observed to be internalized
specifically within epithelial cells displaying M-like cell characteristics.
Conclusion: These data indicate that C. jejuni may utilize M cells to promote transcytosis of non-invasive bacteria
across the intact intestinal epithelial barrier. This mechanism may contribute to the inflammatory immune
responses against commensal intestinal bacteria commonly observed in IBD patients.
Background
Inflammatory bowel diseases (IBD) are chronic T cell-
mediated diseases that are thought to result from the
loss of immunologic tolerance towards commensal
intestinal microorganisms [1]. Intestinal epithelial barrier
dysfunction is proposed to be a primary factor contri-
buting to IBD pathogenesis [2,3]. By facilitating the
translocation of commensal bacteria across the intestinal
barrier, dysfunction of the epithelium may enable the
inappropriate activation of T lymphocytes that recognize
and respond to constituents of the microbiota. Studies
have shown that IBD patients exhibit increased rates of
systemic endotoxemia [4], have higher amounts of bac-
terial DNA in their serum [5], and have exaggerated
humoral immune responses to intestinal bacterial
antigens [6-8], implying that bacterial antigens are able
to translocate across the intestinal epithelium. Although
several studies have observed elevated intestinal perme-
ability ("leaky gut”) and transcellular uptake of intestinal
antigens in IBD patients [9-11], the mechanisms contri-
buting to this barrier dysfunction have yet to be fully
elucidated.
An increasing number of clinical studies have indicated
that in some patients, IBD onset or reactivation occurs
following a bout of acute bacterial enteritis [12-15].
Recently, two controlled cohort studies have implicated
that enteritis incited by Campylobacter or Salmonella,
which are the leading causes of bacterial enteritis in
many countries, is a risk factor for subsequent develop-
ment of IBD [16,17]. Although the mechanisms involved
are unknown, pathogen-mediated intestinal epithelial
barrier dysfunction may facilitate the translocation of
commensal bacteria across the epithelium. In this regard,
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we have recently shown that C. jejuni induces transloca-
tion of non-invasive commensal bacteria across the
intestinal epithelium via an uncharacterized transcellular
mechanism involving lipid raft-mediated endocytosis
[18,19].
Microfold or M cells are specialized epithelial cells
that sample antigens from the mucosal surface and
transport them via a transcellular route to the basolat-
eral membrane (herein defined as “transcytosis”). Intest-
inal M cells are primary found within the follicle-
associated epithelium (FAE) of Peyer’s patches and iso-
lated lymphoid follicles, but are also occasionally found
interspersed amongst the absorptive enterocytes of villar
epithelium [20]. While M cells are principally involved
in immune surveillance of intestinal antigens, they also
represent an important portal by which enteric bacteria
can translocate across the intestinal barrier [21]. Studies
have suggested that pathogens may exploit M cell func-
tion and upregulate the rate of bacterial transcytosis by
either stimulating de novo formation of M cells
[20,22,23] or increasing the rate of uptake for pre-exist-
ing M cells [24]. While controversy exists with respect
to which of these mechanisms is responsible for
increased bacterial trafficking, it is clear that certain
pathogenic microorganisms can alter M cell function
and increase the rate of transcytosis.
M cell trafficking of bacteria has been studied in vitro
using polarized Caco-2 monolayers which have been sti-
mulated to differentiate into M-like cells by co-culture
with B lymphocytes [25]. Subsequent studies have
shown that M-like cells capable of transporting non-
invasive Vibrio cholerae are naturally present in Caco-2
monolayers despite the absence of B lymphocytes [26].
The resultant M-like cells display many of the in vivo
characteristics of M cells including increased ability to
ingest and transport exogenous particles, disorganized
microvilli structure, decreased absorptive intestinal
epithelial enzyme activities, reduced binding of the lec-
tin, Ulex europaeus agglutinin-1 (UEA-1), and increased
expression of the M-cell specific marker, galectin-9 [27].
We utilized Caco-2 monolayers to test the hypothesis
that C. jejuni induces trancytosis of non-invasive com-
mensal bacteria across the intestinal epithelium through
M-like cells. Specifically, the objectives were to deter-
mine if C. jejuni: (1) increases transcytosis of non-inva-
sive E. coli across polarized Caco-2 monolayers; (2)
increases the abundance of M-like cells within Caco-2
monolayers; and (3) induces internalization of non-inva-
sive E. coli specifically within M-like cells.
Results and discussion
Our previous findings indicate that C. jejuni 81-176
induces transcytosis of non-invasive E. coli ("commensal
bacteria”) across polarized human colonic T84 monolayers
[18]. Since other studies have shown that certain bacteria
can rapidly up-regulate M cell-mediated antigen transcyto-
sis [20,22-24,28], we examined whether C. jejuni utilizes
M-like cells to facilitate intestinal epithelial transcytosis of
non-invasive bacteria. The T84 cell line has not been char-
acterized with respect to the presence of M-like cells; thus
for this current study, we used Caco-2 monolayers in
which M-like cells have previously been characterized
[25,26] in order to assess whether C. jejuni 81-176 induces
translocation of non-invasive E. coli. In agreement with
our previous study using T84 monolayers, we observed
that C. jejuni induced internalization (~1.4-fold; P = 0.023)
and translocation (~7.5-fold; P = 0.023) of E. coli across
polarized Caco-2 monolayers. Furthermore, there were no
changes in paracellular permeability to a 3 kDa dextran
probe (P = 0.13) and transepithelial electrical resistance
(TER) remained above 250 Ω × cm2 (P = 0.39; Table 1)
which is indicative of intact tight epithelial junctions in
this cell type. This supports our previous observations that
a transcellular mechanism is responsible for C. jejuni-
mediated E. coli translocation. Similarly, a recent study
showed that the enteric pathogen, Yersinia pseudotubercu-
losis, also induces translocation of exogenous particles
across both Caco-2 monolayers and human intestinal
epithelium by an as yet uncharacterized transcellular
mechanism [29]. This novel transcellular mechanism of
barrier dysfunction contrasts with the paracellular
mechanism described for many enteric pathogens such as
enterohemorrhagic E. coli and Salmonella, which increase
intestinal permeability by disrupting epithelial tight junc-
tions [30].
C. jejuni-treated monolayers displayed an overall
reduction in absorptive epithelial enzymatic activities
(Table 2). Specifically, alkaline phosphatase was
decreased by ~9.2% (P = 0.01), lactase was decreased by
~8.3% (P = 0.001), and sucrase was decreased by 28%
(P = 0.046). This is consistent with the previously
reported decrease in intestinal sucrase-isomaltase
Table 1 E. coli translocation and internalization, and
epithelial permeability in Caco-2 monolayers treated
with E. coli C25 alone (control) versus monolayers
inoculated with E. coli C25 and C. jejuni 81-176
Control C. jejuni P
Translocated E. coli (log10 CFU/mL) 0.19 ± 0.19 1.42 ± 0.296 0.023
Internalized E. coli (log10 CFU/mL) 3.66 ± 0.36 4.97 ± 0.07 0.023
Initial TER (Ω × cm2) 298 ± 4.2 311 ± 9.4 0.28
Final TER (Ω × cm2) 354 ± 19.7 335 ± 2.1 0.39
Permeability (% apical dextran
recovered)
0.95 ± 0.02 1.01 ± 0.02 0.13
Data are expressed as mean ± SEM, n = 3 independent experiments.
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activity that occurs in the Caco-2 monolayers upon dif-
ferentiation to M-like cells [25]. Notably, intestinal alka-
line phosphatase has been recently show to detoxify
lipopolysaccharide (a component of Gram negative bac-
teria cell walls) and prevent bacterial translocation [31],
suggesting that reduced alkaline phosphatase activity
may be one of the factors contributing to transcytosis of
E. coli in C. jejuni-treated monolayers. Also, transient
lactose malabsorption has been observed following
campylobacteriosis [32], this may warrant further
investigation.
Microscopic analysis revelled an increase (P = 0.002)
in the number of cells that stained positive for galectin-
9 in C. jejuni-treated (11.6 ± 0.5%) versus control (2.9 ±
0.5%) monolayers. Furthermore, in C. jejuni-treated
monolayers, E. coli were primarily associated with Caco-
2 cells displaying characteristics of M-like cells, namely
those that displayed reduced apical binding of UEA-1
lectin and increased expression of galectin-9 (Figure 1).
In contrast, control monolayers exhibited very few
galectin-9 positive cells or associated E. coli. Caco-2
monolayers were sectioned using confocal laser analysis,
and for each section in the z-axis, E. coli were coloured
according to depth from yellow (extracellular) to blue
(intracellular). In C. jejuni-treated monolayers, intracel-
lular E. coli were associated with UEA-1-negative Caco-
2 cells (Figure 2). The few extracellular bacteria were
associated with UEA-1-positive Caco-2 cells (i.e.,
absorptive enterocytes). In control monolayers, only the
occasional extracellular E. coli was observed (not
shown). While cautious interpretation of data resulting
from M cell staining is necessary owing to lack of a uni-
versally accepted human M cell marker, it appears that
our collective data indicate that C. jejuni converts Caco-
2 cells into cells displaying biochemical, functional, and
histological features of M cells. In a similar manner, the
differentiation of M-like cells has been shown to occur
in response to bacterial infection and inflammation
[20,22,33-35].
An important observation is that the epithelial
responses appear to be specific to C. jejuni, since E. coli
alone does not cause appreciable formation of M-like
cells within Caco-2 monolayers. Although we are unsure
of the exact mechanism, current studies have demon-
strated that metabolic stress increases internalization
and translocation of non-pathogenic E.coli across the
intestinal epithelium [36,37]. We and other have pre-
viously noted swollen mitochondria (indicative of meta-
bolic stress) in cell culture and animal models of
campylobacteriosis [38-42]. It appears that mucosal
pathogens often target the mitochondria as part of their
common pathogenic strategy [43]. Thus, one possible
explanation for our observations could be that increased
M cell formation and subsequent transcytosis occur as a
consequence of metabolic stress associated with C.
jejuni pathogenesis.
Controversy continues on whether M cells arise from a
distinct pre-determined lineage of crypt stem cells, or
whether absorptive enterocytes exhibit phenotypic plasti-
city and can be “converted” to M cells [21,24]. Since
immortalized Caco-2 cells are not terminally differentiated
but rather resemble crypt stem cells [44,45], they are thus
theoretically able to differentiate into different epithelial
lineages such as absorptive enterocytes or M-like cells.
Table 2 Intestinal epithelial enzyme activities for Caco-2
monolayers treated with E. coli C25 alone (control) verses
monolayer treated with E. coli C25 and C. jejuni 81-176
Control C. jejuni P
(units/g protein) (units/g protein)
Alkaline Phosphatase 67.6 ± 1.3 61.4 ± 0.5 0.01
Lactase 217.6 ± 1.8 199.6 ± 1.3 0.001
Sucrase 77.5 ± 4.5 55.8 ± 6.1 0.046
Data are expressed as mean ± SEM, n = 3 independent experiments.
Figure 1 Representative epifluorescent micrographs of Caco-2 monolayers stained with the absorptive enterocyte marker Ulex
europaeus agglutinin-1 (red), the M-like cell specific marker galectin-9 (green diffuse cellular staining), and Hoechst nuclear stain
(blue). (a) Monolayers treated with GFP Escherichia coli C25 (arrows) and C. jejuni 81-176. (b) Monolayers treated with only GFP E. coli C25
(control). Bar = 2 μm.
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The rapid timing with which E. coli translocation occurred
following C. jejuni infection (i.e., 6 h), suggests that C.
jejuni may target progenitor M-like cells within the mono-
layer rather than convert fully differentiated epithelial cells
into M-like cells. Future studies are necessary to under-
stand the precise mechanisms by which M-like cells origi-
nate in response to C. jejuni.
Conclusion
Our data indicates that C. jejuni may utilize M cells to
promote transcytosis of non-invasive bacteria across the
intact intestinal epithelial barrier. Based on previous
clinical observations, microscopic aphtoid lesions of the
FAE (i.e., regions containing M cells) appear to be the
initial site of inflammation in patients with Crohn’s dis-
ease [46]. Notably, a recent study of patients with
Crohn’s disease reported increased transmucosal uptake
of non-pathogenic E. coli across the ileal FAE despite
unaltered epithelial permeability [47], suggesting that
trancellular defects in the FAE contribute to the patho-
physiology of IBD. M cells may play an important role
in IBD pathogenesis by increasing transcytosis of com-
mensal bacteria to the inductive sites of mucosal
immune responses [48]. Campylobacter enteritis has
been recently identified as a risk factor for IBD [16,17].
By increasing M cell-mediated trancytosis of non-
invasive bacteria, C. jejuni may contribute to the activa-
tion of T lymphocyte-mediated immune responses
against commensal bacteria commonly observed in IBD
patients. Future studies will be required to determine
whether C. jejuni-induced M cell-mediated transcytosis
of commensal bacteria occurs in vivo and whether this
causes aberrant T lymphocyte-mediated immune
responses.
Methods
Bacteria and growth conditions
C. jejuni 81-176, a reference clinical strain [49], was
used throughout this study. For microscopy studies,
Escherichia coli C25 transformed with GFP-expressing
plasmid pMEK91 was used [50]. Inoculum was prepared
by growing C. jejuni or E. coli for 14-16 hours in
Columbia broth (37°C, 100 rpm, Difco, Detroit, MI) in
microaerobic (10% CO2, 3% H2, 5% O2, balance N2) or
aerobic atmosphere, respectively.
Caco-2 M-like cell model
Caco-2 cells (American Type Culture Collection, Mana-
ssas, VA) were grown in Advanced Dulbecco’s minimal
essential medium (DMEM; Gibco Invitrogen Inc., Bur-
lington, ON) supplemented with 10% (v/v) fetal bovine
serum, 200 mM L-glutamine, 100 U/mL penicillin,
Figure 2 Confocal laser sections of Caco-2 monolayers treated with C. jejuni 81-176 plus non-invasive GFP Escherichia coli C25
(arrows) and stained with the absorptive enterocyte marker Ulex europaeus agglutinin-1 (red). E. coli are color-coded according to their
respective depth within the monolayer from extracellular (yellow) to intracellular (blue). (a) Merge of all confocal laser sections. (b-e)
Representative confocal laser sections starting from the apical surface of the monolayer (E. coli color-coded yellow) to the basolateral surface of
the monolayer (E. coli color-coded blue).
Kalischuk et al. Gut Pathogens 2010, 2:14
http://www.gutpathogens.com/content/2/1/14
Page 4 of 7
100 μg/mL streptomycin, 80 μg/mL tylosin (all from
Sigma-Aldrich, Oakville, ON), and incubated at 37°C
and 5% CO2. For E. coli translocation and internaliza-
tion, epithelial permeability, and enzyme activity assays,
cells were seeded onto Transwell filters (3 μm pore size,
1.13 cm2; Costar Corning Inc., Corning, NY) at 1.5 ×
105 cells per filter and grown for 21 days. For micro-
scopy, cells were seeded into chamber slides (Nalgene
Nunc International, Naperville, IL) at 3 × 105 cells per
well.
E. coli translocation and internalization assays
E. coli translocation and internalization were determined
as previously described [18]. Briefly, transwell-grown
monolayers were washed with Hank’s buffered saline
(HBS; Gibco) and antibiotic-free DMEM was added to
the apical and basal compartments. E. coli inoculum was
added to the apical compartment of all monolayers to
achieve a multiplicity of infection (MOI) of 100 CFU
per enterocyte. Monolayers were then divided in to two
groups and half were inoculated with C. jejuni at a MOI
of 100, whereas the other half received an equivalent
volume of sterile broth (control treatment).
Following incubation, E. coli recovered in the basal
compartment (indicating translocation) were enumerated
by spreading serial dilutions onto MacConkey agar, incu-
bating the cultures aerobically at 37°C, and enumerating
at the dilution yielding 30-300 colony forming units
(CFU) per culture. A preliminary experiment confirmed
that 6 h was the minimum optimal incubation time for
assessing E. coli translocation. To assess E. coli internali-
zation, treated monolayers were washed with HBS and
incubated for 1 hour with DMEM containing gentamicin
(250 μg/mL; Sigma). Monolayers were then washed, lysed
with 0.1% Triton X-100 in PBS (500 μL), and viable bac-
teria were enumerated as described above. A preliminary
experiment confirmed that E. coli were killed by the gen-
tamicin treatment. Transepithelial electrical resistance
was monitored at the beginning and end of each experi-
ment with an electrovoltohmeter (World Precision
Instruments, Sarasota, FL). Only monolayers with an
initial TER > 225 Ω × cm2 were used.
Epithelial permeability assay
Transwell-grown monolayers were inoculated with E.
coli ± C. jejuni as described above, and monolayers were
washed with Ringer’s buffer 6 hours after inoculation. A
3 kDa FITC-dextran probe (100 mM in Ringer’s buffer;
500 μL per well; Molecular Probes, Eugene, OR) was
added to the apical compartment and 1 mL of Ringer’s
buffer was added to the basal compartment, and the
monolayers were incubated for 3 hours at 37°C as
described previously [18]. Samples (200 μl) were col-
lected from the basal compartment and the absorbance
at 485 nm was measured. Data were expressed as % api-
cal dextran recovered in the basal compartment.
Epithelial enzyme activity assays
Transwell-grown monolayers were inoculated with
E. coli ± C. jejuni as described above. After 6 hours,
monolayers were washed with PBS and lysed with 0.2%
Triton X-100 in PBS (500 μL per well) on ice for
20 minutes. Cell lysates were clarified by centrifugation
(2 minutes, 16,000 (g). Total protein concentration of
the lysates was determined using the Bradford protein
assay (Bio-Rad, Mississauga, ON) and were calculated by
interpolation of a standard curve generated with known
concentrations of bovine serum albumin (BSA).
Alkaline phosphatase activity was measured by hydro-
lysis of p-nitrophenyl phosphate (pNPP; Sigma) reagent
according to the manufacturer’s instructions. Briefly, cell
lysates (20 μL) were incubated for 30 minutes at 37°C
with pNPP reagent (500 μL). The reaction was stopped
with 2 M NaOH (150 μL) and measured spectrophoto-
metrically at A410 nm. Enzyme activity was calculated by
interpolation of a standard curve generated with alkaline
phophatase of defined activity. Enzyme activity was
expressed as units/g protein, where 1 unit is defined as
the amount of enzyme that hydrolyzed 1 μM of pNPP
per minute at 37°C.
Sucrase and lactase activities were measured according
to the method of Dahlqvist [51]. In brief, cell lysates
(50 μL) were incubated with sucrose or lactose (50 μL
of 100 mM disaccharide in 0.1 M maleate buffer, pH 6;
Sigma) in each of two separate tubes. One set of tubes,
used to measure background endogenous glucose in the
sample, was heated at 95°C for 2 minutes. The second
set of tubes was placed in a 37°C water bath for 4 hours
followed by 95°C for 2 minutes. Glucose oxidase reagent
(200 μL; Sigma) was added to each tube and then in-
cubated at 37°C for 1 hour. A coloured product of
O-dianisidine, which is produced based on the amount
of glucose liberated in the samples, was measured spec-
trophotometrically at A420 nm. Glucose in each lysate
was calculated by interpolation of a glucose standard
curve. Enzyme activity was expressed as units/g protein,
where 1 unit is defined as the amount of enzyme that
liberated 1 μM of glucose in 1 hour.
M cell staining, epifluorescent and confocal microscopy
Confluent Caco-2 monolayers grown on chamber slides
were inoculated with E. coli ± C. jejuni as described
above. Caco-2 monolayers were washed with PBS
6 hours after inoculation, and fixed in paraformaldehyde
(2%). Galectin-9 staining was performed as previously
described [27]. Briefly, slides were washed with PBS,
incubated with glycine (1% in PBS) for 15 minutes,
and washed with PBS. Cells were permeabilized for
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10 minutes with Triton X-100 (0.5% in PBS), blocked
with BSA (2% in PBS), incubated with goat anti-human
Galectin-9 antibodies (1% in PBS; R&D Systems Inc.,
Minneapolis, MN) followed by Alexa-488 conjugated
anti-goat IgG (0.2% in PBS; Molecular Probes). Mono-
layers were then washed with PBS and incubated for 30
minutes with TRITC-conjugated UEA-1 (5 μg/mL in
PBS; Sigma). After washing with PBS, slides were stained
for 15 minutes with Hoechst nuclear stain (1 μM; Mole-
cular Probes) and washed with PBS. Coverslips were
mounted with Aqua-Mount (Lerner Laboratories, Pitts-
burgh, PA) according to the manufacturer’s instructions.
Slides were examined by epifluorescent microscopy
using appropriate filters. Slides were blinded by taping
the labels, and a grid was drawn on the back of each
slide. The same section of the grid was examined by epi-
fluorescent microscopy and scored for total number of
cells and number of M cells (i.e., galectin-9 positive,
UEA negative). Confocal optical sectioning was carried
out using an inverted microscope equipped with a con-
focal laser scanning imaging system (Leica Microsys-
tems, Wetzler, Germany).
Statistical analysis
Each assay was conducted at least three times on sepa-
rate occasions. For each replicate, observations were
conducted at least in triplicate, and mean values were
used for analysis. Data are expressed as means ± SEM.
Unpaired Student’s t-test were used to compare means
of control versus C. jejuni-treated samples (GraphPad
InStat software, GraphPad Software Inc., San Diego,
CA). P ≤ 0.05 was considered significant.
Acknowledgements
We thank Dr. ME Konkel, Washington State University, for the gift of
pMEK91. This work was supported by an AAFC Peer Review Grant to GDI
and LKT.
Authors’ contributions
LKT participated in the design of the study, performed experiments,
conducted data analysis, and drafted the manuscript. FL conducted confocal
microscopy and image analysis. GDI participated in the design of the study
and edited the manuscript. All authors read and approved the final
manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 15 September 2010 Accepted: 1 November 2010
Published: 1 November 2010
References
1. Maul J, Duchmann R: Can loss of immune tolerance cause IBD? Inflamm
Bowel Dis 2008, 14(Suppl 2):S115-116.
2. Su L, Shen L, Clayburgh DR, Nalle SC, Sullivan EA, Meddings JB, Abraham C,
Turner JR: Targeted epithelial tight junction dysfunction causes immune
activation and contributes to development of experimental colitis.
Gastroenterology 2009, 136:551-563.
3. Laukoetter MG, Nava P, Nusrat A: Role of the intestinal barrier in
inflammatory bowel disease. World J Gastroenterol 2008, 14(3):401-407.
4. Gardiner KR, Halliday MI, Barclay GR, Milne L, Brown D, Stephens S,
Maxwell RJ, Rowlands BJ: Significance of systemic endotoxaemia in
inflammatory bowel disease. Gut 1995, 36:897-901.
5. Gutierrez A, Frances R, Amoros A, Zapater P, Garmendia M, Ndongo M,
Cano R, Jover R, Such J, Perez-Mateo M: Cytokine association with
bacterial DNA in serum of patients with inflammatory bowel disease.
Inflamm Bowel Dis 2009, 15:508-514.
6. Duchmann R, Kaiser I, Hermann E, Mayet W, Ewe K, Meyer zum
Buschenfelde KH: Tolerance exists towards resident intestinal flora but is
broken in active inflammatory bowel disease (IBD). Clin Exp Immunol
1995, 102:448-455.
7. Adams RJ, Heazlewood SP, Gilshenan KS, O’Brien M, McGuckin MA,
Florin TH: IgG antibodies against common gut bacteria are more
diagnostic for Crohn’s disease than IgG against mannan or flagellin. Am
J Gastroenterol 2008, 103:386-396.
8. Macpherson A, Khoo UY, Forgacs I, Philpott-Howard J, Bjarnason I: Mucosal
antibodies in inflammatory bowel disease are directed against intestinal
bacteria. Gut 1996, 38:365-375.
9. Soderholm JD, Streutker C, Yang PC, Paterson C, Singh PK, McKay DM,
Sherman PM, Croitoru K, Perdue MH: Increased epithelial uptake of
protein antigens in the ileum of Crohn’s disease mediated by tumour
necrosis factor alpha. Gut 2004, 53:1817-1824.
10. Schurmann G, Bruwer M, Klotz A, Schmid KW, Senninger N, Zimmer KP:
Transepithelial transport processes at the intestinal mucosa in
inflammatory bowel disease. Int J Colorectal Dis 1999, 14:41-46.
11. Porras M, Martin MT, Yang PC, Jury J, Perdue MH, Vergara P: Correlation
between cyclical epithelial barrier dysfunction and bacterial
translocation in the relapses of intestinal inflammation. Inflamm Bowel
Dis 2006, 12:843-852.
12. Halfvarson J, Jess T, Magnuson A, Montgomery SM, Orholm M, Tysk C,
Binder V, Jarnerot G: Environmental factors in inflammatory bowel
disease: a co-twin control study of a Swedish-Danish twin population.
Inflamm Bowel Dis 2006, 12:925-933.
13. Mylonaki M, Langmead L, Pantes A, Johnson F, Rampton DS: Enteric
infection in relapse of inflammatory bowel disease: importance of
microbiological examination of stool. Eur J Gastroenterol Hepatol 2004,
16:775-778.
14. Stallmach A, Carstens O: Role of infections in the manifestation or
reactivation of inflammatory bowel diseases. Inflamm Bowel Dis 2002,
8:213-218.
15. Ruigomez A, Garcia Rodriguez LA, Panes J: Risk of irritable bowel
syndrome after an episode of bacterial gastroenteritis in general
practice: influence of comorbidities. Clin Gastroenterol Hepatol 2007,
5:465-469.
16. Garcia Rodriguez LA, Ruigomez A, Panes J: Acute gastroenteritis is
followed by an increased risk of inflammatory bowel disease.
Gastroenterology 2006, 130:1588-1594.
17. Gradel KO, Nielsen HL, Schonheyder HC, Ejlertsen T, Kristensen B, Nielsen H:
Increased short- and long-term risk of inflammatory bowel disease after
Salmonella or Campylobacter gastroenteritis. Gastroenterology 2009,
137:495-501.
18. Kalischuk LD, Inglis GD, Buret AG: Campylobacter jejuni induces
transcellular translocation of commensal bacteria via lipid rafts. Gut
Pathog 2009, 1:2.
19. Kalischuk LD, Buret AG: A role for Campylobacter jejuni-induced enteritis
in inflammatory bowel disease? Am J Physiol Gastrointest Liver Physiol
2009, 298:G1-9.
20. Jang MH, Kweon MN, Iwatani K, Yamamoto M, Terahara K, Sasakawa C,
Suzuki T, Nochi T, Yokota Y, Rennert PD, et al: Intestinal villous M cells: an
antigen entry site in the mucosal epithelium. Proc Natl Acad Sci USA
2004, 101:6110-6115.
21. Kerneis S, Pringault E: Plasticity of the gastrointestinal epithelium: the M
cell paradigm and opportunism of pathogenic microorganisms. Semin
Immunol 1999, 11:205-215.
22. Borghesi C, Taussig MJ, Nicoletti C: Rapid appearance of M cells after
microbial challenge is restricted at the periphery of the follicle-
associated epithelium of Peyer’s patch. Lab Invest 1999, 79:1393-1401.
Kalischuk et al. Gut Pathogens 2010, 2:14
http://www.gutpathogens.com/content/2/1/14
Page 6 of 7
23. Meynell HM, Thomas NW, James PS, Holland J, Taussig MJ, Nicoletti C: Up-
regulation of microsphere transport across the follicle-associated
epithelium of Peyer’s patch by exposure to Streptococcus pneumoniae
R36a. Faseb J 1999, 13:611-619.
24. Gebert A, Steinmetz I, Fassbender S, Wendlandt KH: Antigen transport into
Peyer’s patches: increased uptake by constant numbers of M cells. Am J
Pathol 2004, 164:65-72.
25. Kerneis S, Bogdanova A, Kraehenbuhl JP, Pringault E: Conversion by Peyer’s
patch lymphocytes of human enterocytes into M cells that transport
bacteria. Science 1997, 277:949-952.
26. Blanco LP, DiRita VJ: Bacterial-associated cholera toxin and GM1 binding
are required for transcytosis of classical biotype Vibrio cholerae through
an in vitro M cell model system. Cell Microbiol 2006, 8:982-998.
27. Pielage JF, Cichon C, Greune L, Hirashima M, Kucharzik T, Schmidt MA:
Reversible differentiation of Caco-2 cells reveals galectin-9 as a surface
marker molecule for human follicle-associated epithelia and M cell-like
cells. Int J Biochem Cell Biol 2007, 39:1886-1901.
28. Man AL, Lodi F, Bertelli E, Regoli M, Pin C, Mulholland F, Satoskar AR,
Taussig MJ, Nicoletti C: Macrophage migration inhibitory factor plays a
role in the regulation of microfold (M) cell-mediated transport in the
gut. J Immunol 2008, 181:5673-5680.
29. Ragnarsson EG, Schoultz I, Gullberg E, Carlsson AH, Tafazoli F, Lerm M,
Magnusson KE, Soderholm JD, Artursson P: Yersinia pseudotuberculosis
induces transcytosis of nanoparticles across human intestinal villus
epithelium via invasin-dependent macropinocytosis. Lab Invest 2008,
88:1215-1226.
30. Sears CL: Molecular physiology and pathophysiology of tight junctions V.
assault of the tight junction by enteric pathogens. Am J Physiol
Gastrointest Liver Physiol 2000, 279:G1129-1134.
31. Goldberg RF, Austen WG Jr, Zhang X, Munene G, Mostafa G, Biswas S,
McCormack M, Eberlin KR, Nguyen JT, Tatlidede HS, et al: Intestinal alkaline
phosphatase is a gut mucosal defense factor maintained by enteral
nutrition. Proc Natl Acad Sci USA 2008, 105:3551-3556.
32. Lazaro A, Selles H, Calvo MA, Olivares JL, Castillo J, Gomez-Lus F, Bueno M:
[Digestive complications of Campylobacter enteritis]. An Esp Pediatr 1985,
22:275-279.
33. Lugering A, Floer M, Lugering N, Cichon C, Schmidt MA, Domschke W,
Kucharzik T: Characterization of M cell formation and associated
mononuclear cells during indomethacin-induced intestinal inflammation.
Clin Exp Immunol 2004, 136:232-238.
34. Cuvelier CA, Quatacker J, Mielants H, De Vos M, Veys E, Roels HJ: M-cells
are damaged and increased in number in inflamed human ileal mucosa.
Histopathology 1994, 24:417-426.
35. Rhee KJ, Sethupathi P, Driks A, Lanning DK, Knight KL: Role of commensal
bacteria in development of gut-associated lymphoid tissues and
preimmune antibody repertoire. J Immunol 2004, 172:1118-1124.
36. Nazli A, Yang PC, Jury J, Howe K, Watson JL, Soderholm JD, Sherman PM,
Perdue MH, McKay DM: Epithelia under metabolic stress perceive
commensal bacteria as a threat. Am J Pathol 2004, 164:947-957.
37. Lewis K, Caldwell J, Phan V, Prescott D, Nazli A, Wang A, Soderholm JD,
Perdue MH, Sherman PM, McKay DM: Decreased epithelial barrier
function evoked by exposure to metabolic stress and nonpathogenic E.
coli is enhanced by TNF-alpha. Am J Physiol Gastrointest Liver Physiol 2008,
294:G669-678.
38. De Melo MA, Gabbiani G, Pechere JC: Cellular events and intracellular
survival of Campylobacter jejuni during infection of HEp-2 cells. Infect
Immun 1989, 57:2214-2222.
39. Humphrey CD, Montag DM, Pittman FE: Morphologic observations of
experimental Campylobacter jejuni infection in the hamster intestinal
tract. Am J Pathol 1986, 122:152-159.
40. Kalischuk LD, Inglis GD, Buret AG: Strain-dependent induction of epithelial
cell oncosis by Campylobacter jejuni is correlated with invasion ability
and is independent of cytolethal distending toxin. Microbiology 2007,
153:2952-2963.
41. Gao JX, Ma BL, Xie YL, Huang DS: Electron microscopic appearance of the
chronic Campylobacter jejuni enteritis of mice. Chin Med J (Engl) 1991,
104:1005-1010.
42. Newell DG, Pearson A: The invasion of epithelial cell lines and the
intestinal epithelium of infant mice by Campylobacter jejuni/coli. J
Diarrhoeal Dis Res 1984, 2:19-26.
43. Blanke SR: Micro-managing the executioner: pathogen targeting of
mitochondria. Trends Microbiol 2005, 13:64-71.
44. Engle MJ, Goetz GS, Alpers DH: Caco-2 cells express a combination of
colonocyte and enterocyte phenotypes. J Cell Physiol 1998, 174:362-369.
45. Owen RL: Mid-life crisis for M cells. Gut 1998, 42:11-12.
46. Fujimura Y, Kamoi R, Iida M: Pathogenesis of aphthoid ulcers in Crohn’s
disease: correlative findings by magnifying colonoscopy, electron
microscopy, and immunohistochemistry. Gut 1996, 38:724-732.
47. Keita AV, Salim SY, Jiang T, Yang PC, Franzen L, Soderkvist P, Magnusson KE,
Soderholm JD: Increased uptake of non-pathogenic E. coli via the follicle-
associated epithelium in longstanding ileal Crohn’s disease. J Pathol
2008, 215:135-144.
48. Gullberg E, Soderholm JD: Peyer’s patches and M cells as potential sites
of the inflammatory onset in Crohn’s disease. Ann N Y Acad Sci 2006,
1072:218-232.
49. Korlath JA, Osterholm MT, Judy LA, Forfang JC, Robinson RA: A point-
source outbreak of campylobacteriosis associated with consumption of
raw milk. J Infect Dis 1985, 152:592-596.
50. Mixter PF, Klena JD, Flom GA, Siegesmund AM, Konkel ME: In vivo tracking
of Campylobacter jejuni by using a novel recombinant expressing green
fluorescent protein. Appl Environ Microbiol 2003, 69:2864-2874.
51. Dahlqvist A: Method for assay of intestinal disaccharidases. Anal Biochem
1964, 7:18-25.
doi:10.1186/1757-4749-2-14
Cite this article as: Kalischuk et al.: Campylobacter jejuni induces
transcytosis of commensal bacteria across the intestinal epithelium
through M-like cells. Gut Pathogens 2010 2:14.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Kalischuk et al. Gut Pathogens 2010, 2:14
http://www.gutpathogens.com/content/2/1/14
Page 7 of 7
